DE602005005062D1 - Dhydrogele und deren biomedizinischen und pharmazeutischen anwendungen - Google Patents

Dhydrogele und deren biomedizinischen und pharmazeutischen anwendungen

Info

Publication number
DE602005005062D1
DE602005005062D1 DE602005005062T DE602005005062T DE602005005062D1 DE 602005005062 D1 DE602005005062 D1 DE 602005005062D1 DE 602005005062 T DE602005005062 T DE 602005005062T DE 602005005062 T DE602005005062 T DE 602005005062T DE 602005005062 D1 DE602005005062 D1 DE 602005005062D1
Authority
DE
Germany
Prior art keywords
biomedical
dhydrogele
hyaluronic acid
crosslinking
pharmaceutical applications
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005005062T
Other languages
English (en)
Other versions
DE602005005062T2 (de
Inventor
Gaetano Giammona
Giovanna Pitarresi
Fabio Salvatore Palumbo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novagenit Sri Mezzolombardo It
Original Assignee
Universita degli Studi di Palermo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universita degli Studi di Palermo filed Critical Universita degli Studi di Palermo
Publication of DE602005005062D1 publication Critical patent/DE602005005062D1/de
Application granted granted Critical
Publication of DE602005005062T2 publication Critical patent/DE602005005062T2/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
DE602005005062T 2004-06-28 2005-06-23 Hyaluronsäure und alpha-, beta-polyaspartylhydrazidhydrogele und deren biomedizinischen und pharmazeutischen anwendungen Active DE602005005062T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT000318A ITRM20040318A1 (it) 2004-06-28 2004-06-28 Idrogeli di acido ialuronico e alfa, beta-poliaspartilidrazide e loro applicazioni in campo biomedico e farmaceutico.
ITRM20040318 2004-06-28
PCT/IT2005/000364 WO2006001046A1 (en) 2004-06-28 2005-06-23 Hydrogels of hyaluronic acid and alpha, beta-polyaspartylhydrazide and their biomedical and pharmaceutical uses

Publications (2)

Publication Number Publication Date
DE602005005062D1 true DE602005005062D1 (de) 2008-04-10
DE602005005062T2 DE602005005062T2 (de) 2008-12-04

Family

ID=34981530

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005005062T Active DE602005005062T2 (de) 2004-06-28 2005-06-23 Hyaluronsäure und alpha-, beta-polyaspartylhydrazidhydrogele und deren biomedizinischen und pharmazeutischen anwendungen

Country Status (13)

Country Link
US (1) US20080292664A1 (de)
EP (1) EP1773399B1 (de)
JP (1) JP2008504100A (de)
KR (1) KR20070043724A (de)
AT (1) ATE387218T1 (de)
AU (1) AU2005257078B2 (de)
CA (1) CA2572127C (de)
DE (1) DE602005005062T2 (de)
DK (1) DK1773399T3 (de)
ES (1) ES2303258T3 (de)
IT (1) ITRM20040318A1 (de)
PT (1) PT1773399E (de)
WO (1) WO2006001046A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007035778A2 (en) 2005-09-19 2007-03-29 Histogenics Corporation Cell-support matrix and a method for preparation thereof
EP2492285A1 (de) * 2006-03-07 2012-08-29 ProChon Biotech Ltd. Hydrazidderivate von Hyaluronsäure
US8668863B2 (en) 2008-02-26 2014-03-11 Board Of Regents, The University Of Texas System Dendritic macroporous hydrogels prepared by crystal templating
EP2310423A1 (de) 2008-04-28 2011-04-20 SurModics, Inc. Auf poly(1;4)glucopyranose basierende matrizes mit hydrazidvernetzung
CZ2008705A3 (cs) 2008-11-06 2010-04-14 Cpn S. R. O. Zpusob prípravy DTPA sítovaných derivátu kyseliny hyaluronové a jejich modifikace
EP2213315A1 (de) 2009-01-30 2010-08-04 Mero S.r.L. Antibakterielles Hydrogel und dessen Verwendungen in der Orthopädie
IT1401498B1 (it) 2010-07-30 2013-07-26 Mero Srl Idrogelo a base di acido ialuronico e suo uso in ortopedia
WO2012048283A1 (en) 2010-10-08 2012-04-12 Board Of Regents, The University Of Texas System One-step processing of hydrogels for mechanically robust and chemically desired features
JP6042815B2 (ja) 2010-10-08 2016-12-14 ザ ボード オブ リージェンツ オブ ザ ユニバーシティ オブ テキサス システム 生物医学的応用のためのアルギン酸塩及びヒアルロン酸を用いる抗癒着性バリア膜
US11565027B2 (en) 2012-12-11 2023-01-31 Board Of Regents, The University Of Texas System Hydrogel membrane for adhesion prevention
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
WO2017040906A1 (en) * 2015-09-04 2017-03-09 The Board Of Regents Of The University Of Texas System Di-functionalized hyaluronic acid derivatives and hydrogels thereof
KR101872222B1 (ko) * 2016-08-02 2018-06-28 한림대학교 산학협력단 미소막 간격체 및 미소막 간격체-유착방지제 혼합물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616568A (en) * 1993-11-30 1997-04-01 The Research Foundation Of State University Of New York Functionalized derivatives of hyaluronic acid
AU2002239697A1 (en) * 2000-10-24 2002-06-03 Clear Solutions Biotech, Inc. Sodium hyaluronate microspheres
EP1694712A1 (de) * 2003-12-04 2006-08-30 University of Utah Research Foundation Modifizierte makromoleküle und verfahren zu ihrer herstellung und verwendung

Also Published As

Publication number Publication date
ATE387218T1 (de) 2008-03-15
WO2006001046A1 (en) 2006-01-05
ITRM20040318A1 (it) 2004-09-28
CA2572127C (en) 2013-02-05
PT1773399E (pt) 2008-06-05
AU2005257078B2 (en) 2010-04-22
AU2005257078A1 (en) 2006-01-05
DK1773399T3 (da) 2008-06-16
EP1773399A1 (de) 2007-04-18
CA2572127A1 (en) 2006-01-05
KR20070043724A (ko) 2007-04-25
EP1773399B1 (de) 2008-02-27
US20080292664A1 (en) 2008-11-27
ES2303258T3 (es) 2008-08-01
DE602005005062T2 (de) 2008-12-04
JP2008504100A (ja) 2008-02-14

Similar Documents

Publication Publication Date Title
DE602005005062D1 (de) Dhydrogele und deren biomedizinischen und pharmazeutischen anwendungen
Vercruysse et al. Synthesis and in vitro degradation of new polyvalent hydrazide cross-linked hydrogels of hyaluronic acid
Atoufi et al. A novel bio electro active alginate-aniline tetramer/agarose scaffold for tissue engineering: synthesis, characterization, drug release and cell culture study
Kogan et al. Hyaluronic acid: a natural biopolymer with a broad range of biomedical and industrial applications
Guan et al. Synthesis, characterization and cytocompatibility of polyurethaneurea elastomers with designed elastase sensitivity
AU2007216998A8 (en) Segmented degradable polymers and conjugates made therefrom
ATE335011T1 (de) Verfahren zur vernetzung von hyaluronsäure mit polymeren
Foroutan Koudehi et al. Synthesis of molecularly imprinted polymer nanoparticles containing gentamicin drug as wound dressing based polyvinyl alcohol/gelatin nanofiber
Nguyen et al. Injectable poly (amidoamine)-poly (ethylene glycol)-poly (amidoamine) triblock copolymer hydrogel with dual sensitivities: pH and temperature
DE60331367D1 (de) Wirkstofffreisetzung von schnell gelierender polymerzusammensetzung
McLellan et al. Keratin-based biofilms, hydrogels, and biofibers
Stanescu et al. Novel chitosan and bacterial cellulose biocomposites tailored with polymeric nanoparticles for modern wound dressing development
PT1061900E (pt) Composicoes e metodos para libertacao de uma droga
Ebhodaghe Hydrogel–based biopolymers for regenerative medicine applications: a critical review
BRPI0516568A (pt) biomateriais consistindo em ácido hialurÈnico sulfatado e gelana, bem como composição farmacêutica e uso dos mesmos
EP1613663A4 (de) Vernetzte polysaccharidzusammensetzung
MA32394B1 (fr) Composes pegyles d'insuline lispro
DK1543063T3 (da) Medikament levering
WO2007110694A3 (en) Gelling hydrophobic injectable polymer compositions
Peng et al. Synthesis of poly (glutamic acid)-tyramine hydrogel by enzyme-mediated gelation for controlled release of proteins
ATE290564T1 (de) Funktionsfähige poly-alpha-aminosäurederivate zur modifizierung von biologisch wirksamen stoffen und deren herstellung
DE60218061D1 (de) Biologisch abbaubares polymer
Thompson et al. Self‐Assembling Hydrogels Crosslinked Solely by Receptor–Ligand Interactions: Tunability, Rationalization of Physical Properties, and 3D Cell Culture
Salehi Dashtebayaz et al. Interpenetrating networks hydrogels based on hyaluronic acid for drug delivery and tissue engineering
Aduba Jr et al. Electrospun gelatin–arabinoxylan ferulate composite fibers for diabetic chronic wound dressing application

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: NOVAGENIT S.R.I.,, MEZZOLOMBARDO, IT

8328 Change in the person/name/address of the agent

Representative=s name: V. BEZOLD & PARTNER, 80799 MUENCHEN

8364 No opposition during term of opposition